Autolus Therapeutics AUTL
NASDAQ AUTL
$1.78 -0.07 (-3.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Autolus Therapeutics (AUTL) Asset Writedowns and Impairment (2018 - 2026)

Updated

Autolus Therapeutics (AUTL) recorded Asset Writedowns and Impairment of $1.2 million in Q2 2026, down 52.0% from $2.5 million a year earlier.

Analysis

Autolus Therapeutics (AUTL) Asset Writedowns and Impairment (2018 - 2026) Analysis & Trends

On a TTM basis, Autolus Therapeutics' Asset Writedowns and Impairment came in at $12.7 million as of Jun 30, 2026, up 335.8% year-over-year; for FY2025, it came in at $12.3 million.

  • Across earlier years, Asset Writedowns and Impairment came in at $414,000 in FY2024 (+3.5%) and $400,000 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Asset Writedowns and Impairment since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Autolus Therapeutics 631.98 Mn -692.11 Mn 25.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.20 Mn
Dec 31, 2025 4.70 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 2.50 Mn
Jun 30, 2024 414,000.00
Dec 31, 2023 18,000.00
Sep 30, 2023 382,000.00
Mar 31, 2019 43,000.00
Sep 30, 2018 8,000.00
API Access

Autolus Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=AUTL&period=max&api_key=YOUR_API_KEY